Advertisement

Immunologic Research

, Volume 31, Issue 3, pp 231–241 | Cite as

STAT4

A critical regulator of inflammation in vivo
  • Mark H. Kaplan
Article

Abstract

Signal transducer and activator of transcription 4 (STAT4) is a central mediator in generating inflammation during protective immune responses and immune-mediated diseases. In the 8 yr since their first description, STAT4-deficient mice have defined the role of STAT4 in a variety of in vivo model systems. Despite the extensive study and use of these mice, the exact role of STAT4 in vivo is still unclear. In this review, I focus on describing the phenotypes of STAT4-deficient immune responses to pathogens and in diseases. Comparing the effects of STAT4 deficiency among numerous model systems will further enhance the development of a systemic model of STAT4 function in vivo.

Key Words

Signal transducer and activator of transcription 4 Inflammation Interferon-γ Interleukin-12 Pathogenesis Disease models 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Leonard WJ, O'Shea JJ: Jaks and STATs: biological implications. Annu Rev Immunol 1998;16:293–322.PubMedCrossRefGoogle Scholar
  2. 2.
    O'Shea JJ, Gadina M, Schreiber RD: Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002;109(Suppl):S121-S131.PubMedCrossRefGoogle Scholar
  3. 3.
    Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133–146.PubMedCrossRefGoogle Scholar
  4. 4.
    Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu C-Y, Gately MK, Gubler U: A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA 1996;93:14,002–14,007.CrossRefGoogle Scholar
  5. 5.
    Zou J, Presky DH, Wu C-Y, Gubler U: Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits β1 and β2 and JAK kinases. J Biol Chem 1997;272:6073–6077.PubMedCrossRefGoogle Scholar
  6. 6.
    Yamamoto K, Quelle FW, Thierfelder WE, Kreider BL, Gilbert DJ, Jenkins NA, Copeland NG, Silvennoinen C, Ihle JN: Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol 1994;14:4342–4349.PubMedGoogle Scholar
  7. 7.
    Zhong Z, Wen Z, Darnell JE Jr: Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci USA 1994;91: 4806–4810.PubMedCrossRefGoogle Scholar
  8. 8.
    Hoey T, Zhang S, Schmidt N, Yu Q, Ramchandani S, Xu X, Naeger LK, Sun YL, Kaplan MH: Distinct requirements for the naturally occurring splice forms Stat4 α and Stat4 β in IL-12 responses. EMBO J 2003;22:4237–4248.PubMedCrossRefGoogle Scholar
  9. 9.
    Kaplan MH, Sun Y-L, Hoey T, Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996;382:174–177.PubMedCrossRefGoogle Scholar
  10. 10.
    Lawless VA, Zhang S, Ozes ON, Bruns HA, Oldham I, Hoey T, Grusby MJ, Kaplan MH: Stat4 regulates multiple components of IFN-γ-inducing signaling pathways. J Immunol 2000;165:6803–6808.PubMedGoogle Scholar
  11. 11.
    Thierfelder WE, van Deursen JM, Yamamoto K, et al: Requirement for Stat4 in interleukin-12 mediated responses of natural killer and T cells. Nature 1996; 382:171–174.PubMedCrossRefGoogle Scholar
  12. 12.
    Ouyang W, Jacobson NG, Bhattacharya D, Gorham JD, Fenoglio D, Sha WC, Murphy TL, Murphy KM: The Ets transcription factor ERM is Th1-specific and induced by IL-12 through a Stat4-dependent pathway. Proc Natl Acad Sci USA 1999;96:3888–3893.PubMedCrossRefGoogle Scholar
  13. 13.
    White SJ, Underhill GH, Kaplan MH, Kansas GS: Cutting edge: differential requirements for Stat4 in expression of glycosyltransferases responsible for selectin ligand formation in Th1 cells. J Immunol 2001;167: 628–631.PubMedGoogle Scholar
  14. 14.
    Lim YC, Xie H, Come CE Alexander SI, Grusby MJ, Lichtman AH, Luscinskas FW: IL-12, STAT4-dependent up-regulation of CD4(+) T cell core 2 beta-1,6-n-acetyl-glucosaminyltransferase, an enzyme essential for biosynthesis of P-selectin ligands. J Immunol 2001; 167:4476–4484.PubMedGoogle Scholar
  15. 15.
    Kaplan MH, Wurster AL, Grusby MJ: A Stat4-independent pathway for the development of Th1 cells. J Exp Med 1998;188:1191–1196.PubMedCrossRefGoogle Scholar
  16. 16.
    Kishimoto K, Dong VM, Issazadeh S, et al: The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 2000;106:63–72.PubMedCrossRefGoogle Scholar
  17. 17.
    Shi HN, Grusby MJ, Nagler-Anderson C: Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. J Immunol 1999;162:5143–5148.PubMedGoogle Scholar
  18. 18.
    Chang HC, Zhang S, Kaplan MH: Neonatal tolerance in the absence of Stat4- and Stat6-dependent Th cell differentiation. J Immunol 2002;169:4124–4128.PubMedGoogle Scholar
  19. 19.
    Chitnis T, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ: Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo. J Immunol 2004; 172:4260–4265.PubMedGoogle Scholar
  20. 20.
    Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ: Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest 2001;108: 739–747.PubMedCrossRefGoogle Scholar
  21. 21.
    Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, Czipri M, Mikecz K, Zhang J: IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol 2002;169:3345–3352.PubMedGoogle Scholar
  22. 22.
    Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, Bhan AK, Terhorst C: T cell—mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 1998;187:1225–1234.PubMedCrossRefGoogle Scholar
  23. 23.
    Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, Rose NR: Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 2001;104:3145–3151.PubMedGoogle Scholar
  24. 24.
    Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, McDuffie M, Nadler JL: Autoimmune diabetes is blocked in Stat4-deficient mice. J Autoimmun 2004; 22:191–200.PubMedCrossRefGoogle Scholar
  25. 25.
    Holz A, Bot A, Coon B, Wolfe T, Grusby MJ, von Herrath MG: Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J Immunol 1999;163: 5374–5382.PubMedGoogle Scholar
  26. 26.
    Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG: Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996;156:5–7.PubMedGoogle Scholar
  27. 27.
    Wang W, Ostlie NS, Conti-Fine BM, Milani M: The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells. J Immunol 2004;172:97–103.PubMedGoogle Scholar
  28. 28.
    Land KJ, Moll JS, Kaplan MH, Seetharamaiah GS: Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism. Endocrinology 2004;145:3724–3730.PubMedCrossRefGoogle Scholar
  29. 29.
    Jacob CO, Zang S, Li L, Ciobanu V, Quismorio F, Mizutani A, Satoh M, Koss M. Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J Immunol 2003;171: 1564–1571.PubMedGoogle Scholar
  30. 30.
    Singh RR, Saxena V, Zang S, Li L, Finkelman FD, Witte DP, Jacob CO. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 2003;170:4818–4825.PubMedGoogle Scholar
  31. 31.
    Tekkanat KK, Maassab H, Berlin AA, Lincoln PM, Evanoff HL, Kaplan MH, Lukacs NW: Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection. Am J Pathol 2001;159:631–638.PubMedGoogle Scholar
  32. 32.
    Raman K, Kaplan MH, Hogaboam CM, Berlin A, Lukacs NW. STAT4 signal pathways regulate inflammation and airway physiology changes in allergic airway inflammation locally via alteration of chemokines. J Immunol 2003;170:3859–3865.PubMedGoogle Scholar
  33. 33.
    Zhou P, Szot GL, Guo Z, Kim O, He G, Wang J, Grusby MJ, Newell KA, Thistlethwaite JR, Bluestone JA, Alegre ML. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol 2000;165:5580–5587.PubMedGoogle Scholar
  34. 34.
    Koglin J, Glysing-Jensen T, Gadiraju S, Russell ME: Attenuated cardiac allograft vasculopathy in mice with targeted deletion of the transcription factor STAT4. Circulation 2000;101:1034–1039.PubMedGoogle Scholar
  35. 35.
    Nikolic B, Lee S, Bronson RT, Grusby MJ, Sykes M: Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest 2000;105:1289–1298.PubMedGoogle Scholar
  36. 36.
    Kato A, Graul-Layman A, Edwards MJ, Lentsch AB: Promotion of hepatic ischemia/reperfusion injury by IL-12 is independent of STAT4. Transplantation 2002;73: 1142–1145.PubMedCrossRefGoogle Scholar
  37. 37.
    Shen XD, Ke B, Zhai Y, Gao F, Anselmo D, Lassman CR, Busuttil RW, Kupiec-Weglinski JW: Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003;37:296–303.PubMedCrossRefGoogle Scholar
  38. 38.
    Yokota N, Burne-Taney M, Racusen L, Rabb H: Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003;285:F319–325.PubMedGoogle Scholar
  39. 39.
    Ostrand-Rosenberg S, Grusby MJ, Clements VK: Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma. J Immunol 2000;165:6015–6019.PubMedGoogle Scholar
  40. 40.
    Zhang SS, Welte T, Fu XY: Dysfunction of Stat4 leads to accelerated incidence of chemical-induced thymic lymphomas in mice. Exp Mol Pathol 2001;70:231–238.PubMedCrossRefGoogle Scholar
  41. 41.
    Cai G, Radzanowski T, Villegas EN, Kastelein R, Hunter CA: Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol 2000;165:2619–2627.PubMedGoogle Scholar
  42. 42.
    Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P: Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol 2002;32:3206–3215.PubMedCrossRefGoogle Scholar
  43. 43.
    Stamm LM, Satoskar AA, Ghosh SK, David JR, Satoskar AR: STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis. Eur J Immunol 1999;29: 2524–2529.PubMedCrossRefGoogle Scholar
  44. 44.
    Tarleton RL, Grusby MJ, Zhang L: Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J Immunol 2000;165:1520–1525.PubMedGoogle Scholar
  45. 45.
    Rodriguez-Sosa M, Monteforte GM, Satoskar AR: Susceptibility to Leishmania mexicana infection is due to the inability to produce IL-12 rather than lack of IL-12 responsiveness. Immunol Cell Biol 2001;79:320–322.PubMedCrossRefGoogle Scholar
  46. 46.
    Fukao T, Frucht DM, Yap G, Gadina M, O'Shea JJ, Koyasu S: Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J Immunol 2001;166:4446–4455.PubMedGoogle Scholar
  47. 47.
    Kaplan MH, Whitfield JR, Boros DL, Grusby MJ: Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol 1998;160: 1850–1856.PubMedGoogle Scholar
  48. 48.
    Rodriguez-Sosa M, Saavedra R, Tenorio EP, Rosas LE, Satoskar AR, Terrazas LI: A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia crassiceps. Infect Immun 2004;72:4552–4560.PubMedCrossRefGoogle Scholar
  49. 49.
    Broxmeyer HE, Bruns HA, Zhang S, et al: Th1 cells regulate hematopoietic progenitor cell homeostasis by production of Oncostatin M. Immunity 2002;16:815–825.PubMedCrossRefGoogle Scholar
  50. 50.
    Kaplan MH, Chang HC, Cooper S, Lee Y, Broxmeyer HE: Distinct requirements for Stat4 and Stat6 in hematopoietic progenitor cell responses to growth factors and chemokines. J Hematother Stem Cell Res 2003; 12:401–408.PubMedCrossRefGoogle Scholar
  51. 51.
    Carter LL, Murphy KM: Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon γ production from CD4+ versus CD8+ T cells. J Exp Med 1999;189:1355–1360.PubMedCrossRefGoogle Scholar
  52. 52.
    Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, Gadina M, O'Shea JJ, Biron CA: Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 2002;297:2063–2066.PubMedCrossRefGoogle Scholar
  53. 53.
    Bot A, Rodrigo E, Wolfe T, Bot S, Von Herrath MG: Infection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens. J Virol 2003;77:5794–5800.PubMedCrossRefGoogle Scholar
  54. 54.
    Chesler DA, Reiss CS: IL-12, while beneficial, is not essential for the host response to VSV encephalitis. J Neuroimmunol 2002;131:92–97.PubMedCrossRefGoogle Scholar
  55. 55.
    Matsukawa A, Kaplan MH, Hogaboam CM, Lukacs NW, Kunkel SL: Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Exp Med 2001; 193:679–688.PubMedCrossRefGoogle Scholar
  56. 56.
    Godshall CJ, Lentsch AB, Peyton JC, Scott MJ, Cheadle WG: STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis. Clin Diagn Lab Immunol 2001;8:1044–1048.PubMedCrossRefGoogle Scholar
  57. 57.
    Lentsch AB, Kato A, Davis B, Wang W, Chao C, Edwards MJ: STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia. J Clin Invest 2001;108:1475–1482.PubMedCrossRefGoogle Scholar
  58. 58.
    Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K, Harada M: The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals. Int Immunol 2004;16:1173–1179.PubMedCrossRefGoogle Scholar
  59. 59.
    Chung DR, Chitnis T, Panzo RJ, Kasper DL, Sayegh MH, Tzianabos AO: CD4+ T cells regulate surgical and postinfectious adhesion formation. J Exp Med 2002;195: 1471–1478.PubMedCrossRefGoogle Scholar
  60. 60.
    Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH, Tzianabos AO: CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 2003;170:1958–1963.PubMedGoogle Scholar
  61. 61.
    Sugawara I, Yamada H, Mizuno S: Relative importance of STAT4 in murine tuberculosis. J Med Microbiol 2003;52:29–34.PubMedCrossRefGoogle Scholar
  62. 62.
    Toyoda H, Ido M, Hayashi T, et al: Impairment of IL-12-dependent STAT4 nuclear translocation in a patient with recurrent Mycobacterium avium infection. J Immunol 2004;172:3905–3912.PubMedGoogle Scholar
  63. 63.
    Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, O'Shea JJ: Activation of Stat4 by IL-12 and IFN-α: evidence for the involvement of ligand induced tyrosine and serine phosphorylation. J Immunol 1996;157:4781–4789.PubMedGoogle Scholar
  64. 64.
    Oppmann B, Lesley R, Blom B, et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715–725.PubMedCrossRefGoogle Scholar
  65. 65.
    Cua DJ, Sherlock J, Chen Y, et al: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421: 744–748.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2005

Authors and Affiliations

  • Mark H. Kaplan
    • 1
  1. 1.Department of Microbiology and ImmunologyIndiana University School of Medicine Walther Oncology CenterIndianapolis

Personalised recommendations